CMP: 18

Brooks Laboratories Limited is a research and development driven pharmaceutical manufacturing company. The Company is a contract manufacturing company for the latest molecules in Injectables and Clavulanic Acid range in Tablets and Dry Syrups.

Brooks Laboratories is a 29 Crore penny cap stock trading at a P/E of just 3 with dividend yields of over 5% in the last 12 months. It runs at a debt of less than 9 Crores and is at pretty safe levels. Revenues have doubled from 28 Crores to 56 Crores in the last 5 years. Profits have grown from less than 4 Crores to almost 9 Crores in the last 5 years. NPM has smartly moved up from 13% to almost 16% over the last 5 years. It has fallen off IPO highs of 130 and has settled down around 15 levels for a year. Brave investors can buy and hold for long term gains.